| 1. Mirani G, Williams PL, Chernoff M, Abzug MJ, Levin MJ, Seage GR 3rd, Oleske JM,
Purswani MU, Hazra R, Traite S, Zimmer B, Van Dyke RB; IMPAACT P1074 Study Team.
Changing Trends in Complications and Mortality Rates Among US Youth and Young Adults
With HIV Infection in the Era of Combination Antiretroviral Therapy. Clin Infect Dis.
2015 Aug 12. pii: civ687.
2. Sirois P, Aaron L, Montepiedra G, Pearson D, Kapetanovic S, Williams P, Garvie P,
Nozyce M, Malee K, Nichols S, Kammerer B, Mitchell W, Mintz M, Oleske J. Stimulant
Medications and Cognition, Behavior, and Quality of Life in Children and Youth with
HIV. The Pediatric Infectious Disease Journal. In press 2015
3. Krogstad P, Patel K, Karalius B, Hazra R, Abzug M Oleske J Seage G, Williams P,
Borkowsky W, Wiznia A, Pinto J, Van Dyke R, Incomplete Immune Reconstitution Despite
Virologic Suppression in HIV-1 Infected Children and Adolescents. Man. #: AIDS-D-14-
01137R1 Accepted for Publication 1/2015.
4. Mitchell CD, Chernoff MC, Seage GR 3rd, Purswani MU, Spiegel HM, Zilleruelo g,
Abitol C, Heckman B, Ponce CB, Oleske JM; IMPAACT 219/219C Study Team. Predictors of
resolution and persistence of renal laboratory abnormalities in pediatric HIV
infection. Pediatr Nephrol. 2015 Jan;30(1):153-65.PubMed PMID: 25149850. |
| | 5. Agarwal N, Vernier E, Ravenscroft S, Schwartz L, Oleske J, Ming X. Slit ventricle
syndrome: A case report of intermittent intracranial hypertension. J Child Neurol.
2013 Jun; 28(6):781-3. PMID: 22805245.
6. Williams PL, Abzug MJ, Jacobson DL, Wang J, Van Dyke RB, Hazra R, Patel K,
DiMaggio LA, McFarland EJ, Silio M, Borkowsky W, Seage GR 3rd, Oleske JM, Geffner ME;
International Maternal Pediatric and Adolescent AIDS Clinical Trials P219219C Study
and the Pediatric HIVAIDS Cohort Study. Pubertal onset in children with perinatal HIV
infection in the era of combination antiretroviral treatment. AIDS. 2013 Jul 31;
27(12):1959-70. PubMed PMID: 24145244.
7. Belilos E, Oleske JM, Medow NB, Sadovsky R, Campese CL, Bello JA, Swan KG. The
Greater Metropolitan Medical Alumni Council (GMMAC): The Realization of a Need. J
Investig Med. 2013 Jun3. PMID: 23736685
8. Naar-King S, Montepiedra G, Garvie P, Kammerer B, Malee K, Sirois PA, Aaron L,
Nichols SL; PACTG P1042s Team (Oleske JM). Social ecological predictors of
longitudinal HIV treatment adherence in youth with perinatally acquired HIV. J
Pediatr Psychol. 2013 Jul; 38(6):664-74. Epub 2013 Apr 28. PMID: 23629146 |
| | 9. Schieffelin JS, Williams PL, Nachman S, Oleske J, Seage III GR, and Van Dyke RB
for the PACTG 219/219C Study Team. Central nervous system vasculopathy in HIV-
infected children in the Pediatric AIDS Clinical Trials Group 219/219C study. Journal
of the Pediatric Infectious Disease Society 2013; 2: 50-56. PMC in process.
10. Patel K, van Dyke RB, Mittleman MA, Colan SD, Oleske JM, Seage GR 3rd; The Impact
of HAART on Cardiomyopathy among Children and Adolescents Perinatally Infected with
HIV-1. for the International Maternal Pediatric Adolescent AIDS Clinical Trials
219219C Study Team. AIDS. 2012 Jul 7. PMID:22781228 PMCID: PMC3513344
11. Gidudu JF, Walco GA, Taddio A, Zempsky WT, Halperin SA, Calugar A, Gibbs NA,
Hennig R, Jovancevic M, Netterlid E, O'Connor T, Oleske JM, Varricchio F, Tsai TF,
Seifert H, Schuind AE; Immunization site pain: Case definition and guidelines for
collection, analysis, and presentation of immunization safety data. The Brighton
Immunization Site Pain Working Group. Vaccine. 2012 Apr 18. PMID: 22521267
12. Purswani MU, Chernoff MC, Mitchell CD, Seage GR 3rd, Zilleruelo G, Abitbol C,
Andiman WA, Kaiser KA, Spiegel H, Oleske JM; Chronic kidney disease associated with
perinatal HIV infection in children and adolescents.The IMPAACT 219/219C Study Team.
Pediatr Nephro. 2012 Jun; 27(6):981-989. Epub 2012 Feb 26. PMID: 22366874 |
| | 13. Nielsen-Saines K, Watts DH, Veloso VG, Bryson YJ, Joao EC, Pilotto JH, Gray G,
Theron G, Santos B, Fonseca R, Kreitchmann R, Pinto J, Mussi-Pinhata MM, Ceriotto M,
Machado D, Bethel J, Morgado MG, Dickover R, Camarca M, Mirochnick M, Siberry G,
Grinsztejn B, Moreira RI, Bastos FI, XU J, Moye J, Mofenson LM; NICHD HPTN 040/PACTG
1043 Protocol Team (Oleske JM). Three postpartum antiretroviral regimens to prevent
intrapartum HIV infection. N Engl J Med. 2012 Jun 21:366(25):2368-79 PMID: 22716975
PMCID: PMC3590113
14. Lujan-Liebermann J, Warshaw MG, Williams PL, Spector SA, Decker MD, Abzug MJ,
Hekman B, Manzella A, Kabat B, Jean-Philippe P, Nachman S, Siberry GK; International
Maternal Pediatric Adolescent AIDS Clinical Trials Group P1065 Protocol Team (Oleske
JM). Immunogenicity and safety of 1 vs 2 doses of quadrivalent meningococcal
conjugate vaccine in youth infected with human immunodeficiency virus. J Pediatr.
2012 Oct; 161(4):676-81.e2. PMID: 22622049 PMCID: PMC3590113
15. Veloso VG, Bryson YJ, Joao EC, Pilotto JH, Gray G, Theron G, Santos B, Fonseca R,
Kreitchmann R, Pinto J, Mussi-Pinhata MM, Ceriotto M, Machado D, Bethel J, Morgado
MG, Dickover R, Camarca M, Mirochnick M, Siberry G, Grinsztejn B, Moreira RI, Bastos
FI, Xu J, Moye J, Mofenson LM, Nielsen-Saines K, Watts NICHD HPTN 040/PACTG 1043
Protocol Team (Oleske, JM); Three postpartum antiretroviral regimens to prevent
intrapartum HIV infection. N Engl J Med. 2012 Jun 21; 66 (2 |
| | 16. Nichols SL, Montepiedra G, Farley JJ, Sirois PA, Malee K, Kammerer B, Garvie PA,
Naar-King S; PACTG P1042S Team (Oleske, JM). Cognitive, academic, and behavioral
correlates of medication adherence in children and adolescents with perinatally
acquired HIV infection. J Dev Behav. Pediatr. 2012 May; 33(4):298-308. PubMed PMID:
22366661; PMCID: PMC3538821.
17. Sejvar JJ, Kohl KS, Gidudu J, Amato A, Bakshi N, Baxter R, Burwen DR, Cornblath
DR, Cleerbout J, Edwards KM, Heininger U, Hughes R, Khuri-Bulos N, Korinthenberg R,
Law BJ, Munro U, Maltezou HC, Neil P, Oleske J, Sparks R, Velentgas P, Vermeer P,
Wiznitzer M; Brighton Collaboration GBS Working Group. Guillain-Barre syndrome and
Fisher syndrome: case definitions and guidelines for collection, analysis, and
presentation of immunization safety data. Vaccine: 2011 Jan 10; 29(3):559-612. PMID:
20600491
18. Malee K, Williams P, Montepiedra G, McCabe M, Nichols S, Sirois PA, Storm D,
Farley J, Kammerer B; for PACTG 219C Team (Oleske JM). Medication adherence in
children and adolescents with HIV infection: associations with behavioral impairment
AIDS Patient Care STDS. Mar 2011; 25(3):191-200. Epub 2011 Feb 16. PubMed PMID:
21323533; PMCID: PMC3101948
|
| | 19. Kapetanovic S, Aaron L, Williams PL, Farley J, Sirois PA, Garvie PA, Oleske JM,
Montepiedra G; The IMPAACT PACTG 291C Team. Relationships between the use of second-
generation antipsychotics and changes in total cholesterol levels in children and
adolescents perinatally infected with HIV. Neurobehav HIV Med. 2010 Aug: 2010(2):39-
48. PubMed PMID: 20865061; PMCID: PMC2943434.
20. Livingston EG, Huo Y, Patel K, Brogly SB, Tumala R, Scott GB, Bardeguez A, Stek
A, Read JS; International Maternal Pediatric Adolescent AIDS Clinical Trials Group
Protocol 1025 Study Team (Oleske JM). Mode of delivery and infant respiratory
morbidity among infants born to HIV-1 infected women Obstet Gynecol. 2010 Aug:
116(2Pt):335-43 PMID: 20664394; PMCID: PMC2964131.
21. Williams PL, Marino M, Malee K, Brogly S, Hughes MD, Mofenson LM; PACTG 219C Team
(Oleske JM). Neurodevelopment and in utero antiretroviral exposure of HIV-exposed
uninfected infants Pediatrics. 2010 Feb; 125(2):e250-60. PMID: 20083530; PMCID:
PMC2951128.
22. Siberry GK, Williams PL, Lujan-Zilbermann J, Warshaw MG, Spector SA, Decker MD,
Heckman BE, Demske EF, Read JS, Jean-Philippe P, Kabat W, Nachman S; IMPAACT P1065
Protocol Team (Oleske JM). Phase I/II, open-label trial of safety and immunogenicity
of meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid
conjugate vaccine in human immunodeficiency virus-infected adolescents. Pediatr
Infect Dis J. 2010 May; 29(5):391-6.PMID |
| | 23. Brogly SB, Abzug MJ, Watts DH, Cunningham CK, Williams PL, Oleske J, Conway D,
Sperling RS, Spiegel H, Van Dyke RB. Birth defects among children born to human
immunodeficiency virus-infected women: pediatric AIDS clinical trials protocols 219
and 219C. Pediatr Infect Dis J. 2010 Aug:29(8):721-7 PMID: 20539252; PMCID:
PMC2948952
24. Crain MJ, Chernoff MC, Oleske JM, Brogly SB, Malee KM, Borum PR, Meyer WA 3rd,
Mitchell WG, Move JH, Ford-Chatterton HM, Van Dyke RB, Seage GR. Possible
mitochondrial dysfunction and its association with antiretroviral therapy use in
children perinatally infected with HIV. J Infect Dis. 2010 Jul; 15; 202(2):291-301.
PMID: 20533872; PMCID: PMC2913975.
25. Brady MT, Oleske JM, Williams PL, Elgie C, Mofenson LM, Dankner WM, Van Dyke RB;
Pediatric AIDS Clinical Trials Group 219/219C Team. Declines in Mortality rates and
changes in causes of death in HIV-1-infected children during the HAART era. J Acquir
Immune Defic Syndr. 2010 Jan; 1; 53(1):86-94. PMID: 20035164;PMCID: PMC2801894. |
| | 26. Kapetanovic S, Aaron L, Montepiedra G, Sirois PA, Oleske JM, Malee K, Pearson DA,
Nichols SL, Garvie PA, Farley J, Nozyce ML, Mintz M, Williams PL. The use of Second-
Generation Antipsychotics and the Changes in Physical Growth in Children and
Adolescents with Perinatally Acquired HIV. AID Patient Care STDS. 2009 Oct; (Vol 23;
No 11):1-9. PMID: 19827949; PMCID: PMC2832650.
27. Sirois PA, Montepiedra G, Kapetanovic S, Williams PL, Pearson DA, Malee K, Garvie
PA, Kammerer BL, Nichols SL, Nozyce ML, Mintz M, Mitchell WG, Oleske JM;
IMPAACT/PACTG 219C Team. Impact of medications prescribed for treatment of attention-
deficit hyperactivity disorder on physical growth in children and adolescents with
HIV. J Dev Behav Pediatr. 2009 Oct; 30(5):403-12. PMID: 19827220; PMCID: PMC2836888
28. Mofenson LM, Brady MT, Danmer SP, Dominguez KL, Hazra R, Handelsman E, havens P,
Nesheim S, Read s, Serchuck L, Van Dyke R, Oleske JM; Guidelines for the Prevention
and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected
children: recommendations from CDC, the national Institutes of Health, the HIV
medicine Association of the Infectious Diseases Society of America, the Pediatric
Infectious Diseases Society, and the American Academy of Pediatrics. MMWR Recomm
Rep.2009 Sep 4; 58(RR-11):1-166. PMID: 19730409; PMCID: PMC2821196.
29. Naar-King S, Montepiedra G, Nichols S, Farley J, Garvie PA, Kammerer B, Malee K,
Sirois PA, Storm D; PACTG P1042S Tea |
| | 30. Patel K, Ming X, Williams PL, Robertson KR, Oleske JM, Seage GR 3rd;
International Maternal Pediatric Adolescent AIDS Clinical Trials 219/219C Study Team.
Impact of HAART and CNS-penetrating antiretroviral regimens on HIV encephalopathy
among perinatal infected women and children. AIDS. 2009 Sep. 10; 23(14):1909-10.
PMID: 19644348; PMCID: PMC2821205
31. Aberg JA, Kaplan JE, Libman H, Emmanuel P, Anderson JR, Stone VE, Oleske JM,
Currier JS, Gallant JE; Primary Care Guidelines for the Management of Persons
Infected with Human Immunodeficiency Virus: 2009 Update by the HIV Medicine
Association of the Infectious Diseases Society of America. Clin Infect Dis; 2009
Sep1; 49(5):651-81. PMID: 19640227
32. Winter HS, Oleske, JM, Hughes, MD, McKinney RE, Elgie C, Powell C, Purdue L, Puga
AM, Jimenez E, Scott GB, Santos Cruz ML, Moye J, for the PACTG 247 Team; Randomized
Controlled Trial of Feeding a Concentrated Formula to Infants Born to Women Infected
by Human Immunodeficiency Virus. J of Pediatr Gastroenterology and Nutrition. 2009
Aug; 49(2):222-32. PMID: 19543114
33. Butler A, Williams P, Howland L, Hutton A, Storm D, Seage GR III. for the PACTG
219C Team (Oleske, J); Disclosure of HIV infection status and health-related quality
of life in children with HIV infection. Pediatrics: 2009 123: 935-943.
|
| | 34. Andiman WA, Chernoff MC, Mitchell C, Purswani M, Oleske J, Williams PL, Spiegel
H, Gona P, Seage GR 3rd; the PACTG IDACS 617 Team. Incidence of Persistent Renal
Dysfunction in Human Immunodeficiency Virus-Infected Children: Associations with the
Use of Antiretrovirals, and other Nephrotoxic Medications and Risk Factors. Pediatr
Infect Dis J. 2009 Jul; 28(7):619-625. PMID: 19561425; PMCID: PMC3192653.
35. Nachman SA, Chernoff M, Gona P, Van Dyke RB, Dankner WM, Seage GR 3rd., Oleske,
J, Williams PL; for PACTG 219C Team; Incidence of noninfectious conditions in
perinatally HIV-infected children and adolescents in the HAART era. Arch Pediatr
Adolesc Med. 2009 Feb; 163(2):164-71. PMID: 19188649; PMCID: PMC2730663.
36. Bardeguez AD, Lindsey JC, Shannon M, Tuomala RE, Cohn SE, Smith E, Stek A,
Buschur S, Cotter A, Bettica L, Read JS; for PACTG 1025 Protocol Team. (Oleske, J)
Adherence to antiretrovirals among US Women during and after pregnancy. J Acquir
Immune Defic Syndr 2008 Aug 1; (48)4:408-17. PMID: 18614923; PMCID: PMC2764488.
37. Tassiopoulos K., Williams PL., Seage GR3rd. Crain M., Oleske J., Farley J.; for
the International Maternal Pediatric Adolescent AIDS Clinical Trials 219C Team.
Association of Hypercholesterolemia Incidence with Antiretroviral Treatment,
Including Protease Inhibitors, Among Perinatally HIV-infected Children. J Acquir
Immune Defic Syndr 2008 Apr 15:47(5):607-614. PMID: 18209684 PMCID: PMC3089963. |
|
